COYAInvestor Conferences•prnewswire•September 3, 2025 at 12:34 PM

Coya Therapeutics to Participate at Upcoming September Investor Conferences

Sentiment:Negative (20)

Summary

(NASDAQ:COYA) HOUSTON, Sept. 3, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders, announces the...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on September 3, 2025 by prnewswire